Weight Loss and Obesity Management Market, by Product & Services (Drugs, Supplements, Equipment, and Services), by Age Group (Children, Adults, and Geriatric), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S

Weight Loss and Obesity Management Market, by Product & Services (Drugs, Supplements, Equipment, and Services), by Age Group (Children, Adults, and Geriatric), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Obesity refers to body fat and body mass index above 25 (overweight) and 30 (obese), respectively. It is one of the most prevalent disease conditions across the world. It affects individuals in developed, emerging, and undeveloped regions. The weight loss and obesity management services involve the use of certain products such as dietary supplements, medications, surgical interventions, and fitness equipment. According to the World Health Organization, when the Body-Mass-Index is greater than or equal to 25, the person is categorized as overweight; and BMI index above 30 is classified as obese.

Market Dynamics

Increasing incidence of obesity in developed and developing economies of the world is expected to assist growth of the weight loss and obesity management market during the forecast period. For instance, according to the WHO reports published in 2018, around 35.8 million disabilities worldwide are caused due to obesity. Furthermore, increasing research and development, and adoption of strategies such as collaborations and development of novel products by market players to expand their geographical footprint is expected to drive growth of the weight loss and obesity management market.

Key features of the study:

  • This report provides in-depth analysis of the global weight loss and obesity management market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global weight loss and obesity management market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, VIVUS Inc., Herbalife Ltd., Apollo Endosurgery (U.S.), Amer Sports, Brunswick Corporation, Cybex International, Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Johnson & Johnson Services, Inc., Kellogg Company, Life Time Fitness Inc., Medtronic, and NutriSystem, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up gradation, market expansion, and marketing tactics
  • The global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market
Detailed Segmentation:
  • Global Weight Loss and Obesity Management Market, By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • Global Weight Loss and Obesity Management Market, By Age Group:
  • Children
  • Adults
  • Geriatrics
  • Global Weight Loss and Obesity Management Market, By Region:
  • North America
  • By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • By Age Group:
  • Children
  • Adults
  • Geriatrics
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • By Age Group:
  • Children
  • Adults
  • Geriatrics
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • By Age Group:
  • Children
  • Adults
  • Geriatrics
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • By Age Group:
  • Children
  • Adults
  • Geriatrics
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • By Age Group:
  • Children
  • Adults
  • Geriatrics
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product & Services:
  • Drugs
  • Bupropion-naltrexone (Contrave)
  • Liraglutide (Saxenda)
  • Lorcaserin (Belviq)
  • Orlistat (Xenical)
  • Phentermine-topiramate (Qsymia)
  • Others
  • Supplements
  • Equipment
  • Fitness Equipment
  • Surgical Equipment
  • Services
  • Consulting Service
  • Online Weight Loss Programs
  • Others
  • By Age Group:
  • Children
  • Adults
  • Geriatrics
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Novo Nordisk A/S *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Takeda Pharmaceutical Company Ltd
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • VIVUS Inc.
  • Herbalife Ltd.
  • Apollo Endosurgery (U.S.)
  • Amer Sports
  • Brunswick Corporation
  • Cybex International
  • Ethicon, Inc.
  • Equinox, Inc.
  • Johnson & Johnson Services, Inc.
  • Kellogg Company
  • Life Time Fitness Inc.
  • Medtronic
  • NutriSystem, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product & Services
Market Snippet, By Age Group
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Restraints
Market Opportunities
Regulatory Scenario
Industry Trend
Merger and Acquisitions
New Product Approvals/Launch
PEST Analysis
4. Global Weight Loss and Obesity Management Market, By Product & Services, 2019 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Bupropion-naltrexone (Contrave)
Liraglutide (Saxenda)
Lorcaserin (Belviq)
Orlistat (Xenical)
Phentermine-topiramate (Qsymia)
Others
Supplements
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Equipment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Fitness Equipment
Surgical Equipment
Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Consulting Service
Online Weight Loss Programs
Others
5. Global Weight Loss and Obesity Management Market, By Age Group, 2019 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Children
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Geriatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Weight Loss and Obesity Management Market, By Region, 2019 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2019 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
South Africa
Central Africa
North Africa
7. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Company Profiles
Novo Nordisk A/S
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Takeda Pharmaceutical Company Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Eisai Co., Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
F. Hoffmann-La Roche Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
VIVUS Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Herbalife Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Apollo Endosurgery (U.S.)
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Amer Sports
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Brunswick Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Cybex International
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Ethicon, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Equinox, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson Services, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Kellogg Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Life Time Fitness Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Medtronic
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
NutriSystem, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on “Weight Loss and Obesity Management Market - Global forecast to 2027”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook